Bayer's elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studiesBusiness Wire • 01/08/24
ClearNote Health Announces Collaboration with Bayer to Investigate Drug Treatment Response by Liquid Biopsy in Prostate CancerBusiness Wire • 12/14/23
Victory Against Bayer! Williams Hart & Boundas Wins Against Monsanto's Roundup WeedkillerBusiness Wire • 12/13/23
MustGrow signs commercial license agreement with Bayer for biocontrol technologies in EMEA regionProactive Investors • 12/11/23
Bayer Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index for Sixth Consecutive YearBusiness Wire • 12/05/23
Bayer Announces Publication of Health Economic Model Evaluation at RSNA, Providing New Insights Into Cost Effectiveness and Capacity Needs of Supplemental Screening Modalities for Dense BreastsBusiness Wire • 11/27/23
Bayer Championing Advancements in Radiology Pipeline and Accelerating AI InnovationBusiness Wire • 11/22/23